Teleflex Incorporated (NYSE:TFX) Receives Average Recommendation of “Hold” from Analysts

Teleflex Incorporated (NYSE:TFX) has earned a consensus recommendation of “Hold” from the ten brokerages that are presently covering the stock, MarketBeat reports. Two research analysts have rated the stock with a sell recommendation, five have given a hold recommendation and three have given a buy recommendation to the company. The average 12-month target price among analysts that have issued ratings on the stock in the last year is $138.50.

A number of analysts have commented on the stock. Weiss Ratings reiterated a “sell (d)” rating on shares of Teleflex in a report on Friday, March 27th. Royal Bank Of Canada reiterated a “sector perform” rating on shares of Teleflex in a report on Tuesday, April 14th. Wells Fargo & Company increased their price objective on shares of Teleflex from $116.00 to $130.00 and gave the company an “equal weight” rating in a report on Friday, February 27th. Raymond James Financial upgraded shares of Teleflex from a “market perform” rating to an “outperform” rating and set a $128.00 price objective for the company in a report on Friday, March 27th. Finally, Wall Street Zen cut shares of Teleflex from a “hold” rating to a “sell” rating in a research note on Saturday, March 7th.

Institutional Trading of Teleflex

Hedge funds have recently made changes to their positions in the company. MassMutual Private Wealth & Trust FSB grew its stake in shares of Teleflex by 57.9% in the 3rd quarter. MassMutual Private Wealth & Trust FSB now owns 210 shares of the medical technology company’s stock valued at $26,000 after buying an additional 77 shares during the period. Banque Cantonale Vaudoise grew its stake in shares of Teleflex by 82.5% in the 4th quarter. Banque Cantonale Vaudoise now owns 250 shares of the medical technology company’s stock valued at $31,000 after buying an additional 113 shares during the period. Hantz Financial Services Inc. grew its stake in shares of Teleflex by 248.8% in the 3rd quarter. Hantz Financial Services Inc. now owns 279 shares of the medical technology company’s stock valued at $34,000 after buying an additional 199 shares during the period. Mirae Asset Global Investments Co. Ltd. purchased a new stake in shares of Teleflex in the 3rd quarter valued at approximately $35,000. Finally, V Square Quantitative Management LLC purchased a new stake in shares of Teleflex in the 4th quarter valued at approximately $37,000. Hedge funds and other institutional investors own 95.62% of the company’s stock.

Teleflex Price Performance

TFX stock traded down $3.59 during mid-day trading on Tuesday, reaching $128.37. The company’s stock had a trading volume of 21,550 shares, compared to its average volume of 938,510. The stock has a market cap of $5.68 billion, a PE ratio of -6.29, a P/E/G ratio of 0.95 and a beta of 0.84. The company has a current ratio of 2.54, a quick ratio of 2.01 and a debt-to-equity ratio of 0.81. Teleflex has a fifty-two week low of $100.18 and a fifty-two week high of $138.93. The company’s 50 day moving average is $114.55 and its two-hundred day moving average is $116.27.

Teleflex (NYSE:TFX) last released its quarterly earnings data on Thursday, February 26th. The medical technology company reported $1.93 EPS for the quarter, missing analysts’ consensus estimates of $3.73 by ($1.80). The business had revenue of $569.00 million during the quarter, compared to analyst estimates of $912.57 million. Teleflex had a negative net margin of 30.56% and a positive return on equity of 14.30%. The firm’s revenue was down 28.5% on a year-over-year basis. During the same quarter in the previous year, the company posted $3.89 EPS. Teleflex has set its FY 2026 guidance at 6.250-6.550 EPS. Equities research analysts expect that Teleflex will post 6.77 EPS for the current year.

Teleflex Announces Dividend

The company also recently declared a quarterly dividend, which was paid on Tuesday, March 31st. Stockholders of record on Friday, March 6th were paid a $0.34 dividend. The ex-dividend date of this dividend was Friday, March 6th. This represents a $1.36 annualized dividend and a dividend yield of 1.1%. Teleflex’s dividend payout ratio is -6.62%.

Teleflex Company Profile

Teleflex Incorporated is a diversified global provider of medical technologies, specializing in critical care and surgery. Headquartered in Wayne, Pennsylvania, the company designs, manufactures and distributes devices and solutions used by healthcare professionals in hospital, ambulatory and alternate site settings. Teleflex focuses on delivering products that support complex interventional procedures and improve patient outcomes.

The company’s offerings span several key segments, including Interventional Urology, Respiratory & Anesthesia, Surgical, Cardiac Care, Vascular and Original Equipment Manufacturer (OEM) solutions.